c-Myc is a multifunctional, nuclear phosphoprotein that plays a role in cell cycle progression, apoptosis and cellular transformation. It functions as a transcription factor that regulates transcription of specific target genes. Mutations, overexpression, rearrangement and translocation of c-Myc have been associated with a variety of hematopoietic tumors, leukemias and lymphomas, including Burkitt’s lymphoma. There is evidence to show that alternative translation initiations from an upstream, in-frame non-AUG (CUG) and a downstream AUG start site result in the production of two isoforms with distinct N-termini. The synthesis of non-AUG initiated protein is suppressed in Burkitt’s lymphomas, suggesting its importance in the normal function of this gene.
Mouse anti-human c-Myc is purified over a protein A column. The protein concentration is 1 mg/ml in PBS after reconstitution. This antibody was produced in BALB/c mice.
Reported to be effective for immunoblotting.
To view protocol(s) for this and other products please visit: www.ATSbio.com/support/protocols